# Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

> **NCT00369473** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 690 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AMG 108
- **DRUG:** AMG 108

## Key facts

- **NCT ID:** NCT00369473
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 690 (ACTUAL)
- **Last updated:** 2016-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369473, "Long-Term Assessment of Safety and Physical Function With AMG 108 in RA". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00369473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*